Introduction {#S1}
============

Substance use disorders (SUDs), which include drug abuse, problematic drug use, drug misuse, and substance misuse, are an important health problem ([@B1]). Persons with SUDs are characterized by multiple social and medical needs and are often known for their difficulty in engaging in treatment, partly because access to treatment facilities is limited ([@B2]). The chronicity and relapsing nature of SUD, as in other psychiatric disorders, entails frequent hospitalizations ([@B3]) and readmissions.

Patients presenting both severe mental illnesses and SUD are typically hospitalized more often than are non-substance users ([@B4], [@B5]). Patients presenting this double diagnosis also have more difficulties entering alcohol and drug outpatient clinics than patients with only SUD ([@B6]). This group of patients seems to have less access to aftercare services ([@B7]) and higher use of acute services, such as emergency room treatment and hospital services ([@B8]).

The period after discharge is characterized by a high risk of relapse, with most cases occurring within the first week of inpatient treatment ([@B9]). There is also an important risk of drug-related death (either accidental or intended) following a longer period of abstinence because of lower drug tolerance ([@B10], [@B11]). These patients have multiple psychosocial problems for which they need support. Patient needs often remain unmet in current outpatient treatment programs ([@B2]), although the provision of help with legal advice, basic needs, and family services may improve patients' psychosocial functioning. Treatment continuity has been related to higher overall abstinence rates ([@B12], [@B13]) and less frequent readmissions to hospital units ([@B14]). Between hospital and community care, treatment continuity is supposed to improve comprehensive support for patients.

Different strategies have been developed to improve treatment adherence and drug-related outcomes ([@B15]); among them, case management (CM) has been identified as potentially beneficial as suggested in early clinical studies ([@B16]). The definition of CM and its practice varies from place to place. In general, CM can be defined as a "coordinated integrated approach to service delivery, ongoing supportive care and help to access resources for living and functioning in the community" ([@B17]). This approach has been widely implemented in many different areas, such as insurance programs, education, and health care.

Given the complex, chronic, and relapsing nature of mental health disorders and SUDs, they require a broad and continuous approach such as can be offered by CM ([@B17]). Since the 1980s, this practice has been adapted for persons with SUD ([@B18]), but to date, only a few studies have described CM models for persons with SUD in Europe.

The aim of this study was thus to assess the effectiveness of CM for patients with SUD. We searched for published articles in which clinical CM was described for patients with SUD to help maintain treatment continuity and coordinate care after a patient was discharged from hospital or prison (transitional CM) or when a patient entered a treatment program.

Method {#S2}
======

The electronic database PubMed was searched for empirical studies published between January 1996 and May 2016. The following keywords were used: "case management" AND "addiction"; "case management" AND "substance use disorder"; "case management" AND "substance abuse." The inclusion criteria were as follows: randomized controlled trial, adult participants over the age of 18 years with SUD, and a CM intervention compared to treatment as usual (TAU).

Results {#S3}
=======

After checking for the inclusion criteria and for duplicates, we analyzed 14 studies (Figure [1](#F1){ref-type="fig"}). Details about the included studies are described in Table [1](#T1){ref-type="table"}. One paper ([@B19]) was reviewed but excluded. It compared assertive community treatment to another form of CM intervention. In absence of a TAU comparison group, the study was not included.

![**Study flow diagram**.](fpsyt-08-00051-g001){#F1}

###### 

**Characteristics of the included studies**.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference, country                              Target population                                                                                                                                                                         Number of subjects                            Control intervention                                                                                                                          CM interventions/dose of CM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Outcome measures                                                                                                                                                                                                          Follow-up                                      Results
  ----------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Guydish et al. ([@B30]), USA                    Drug-involved women offenders on probation or awaiting probation who were willing to enter a substance abuse treatment program                                                            *N* = 183\                                    TAU = standard probation                                                                                                                      12 months of PCM involving uniform assessment procedures, a therapeutic and advocacy orientation, treatment planning, counseling, and home visits. Dosage: at least two contacts per month (visit or phone)                                                                                                                                                                                                                                                                                                        ASI, BDI, BSI, Social Support Evaluation List, service utilization, arrest during 12 months of face time with CM                                                                                                          6 and 12 months                                Proportion of women enrolled in SUD treatment or incarcerated was not statistically different for both groups. All other measures were not statistically different between groups. At 6 months, 53.6% of PCM participants met face-to-face with case manager once or more and at 12 months 43.5% did. In CG, this was 11.6 and 8.5%, respectively. This shows that the dosage was often a lot less than twice a month, as described in the intervention. The participants who had two or more contacts with case manager were more likely to have lower ASI rates and lower social severity rates
                                                                                                                                                                                                                                            IG: *n* = 92; CG: *n* = 91                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Essock et al. ([@B20]), USA                     Alcohol and illicit drug users with a co-occurring major psychotic disorder, who had high service use in the past 2 years, were homeless or unstably housed, and had poor living skills   *N* = 198\                                    Standard clinical CM: comprehensive assessment, individual MI, group treatments, and stage-wise interventions                                 Three years of community-based assertive CM treatment: direct substance abuse treatment by case managers and comprehensive assessment, individual MI, group treatments, and stage-wise interventions. Case managers had half the patient load that they had for CG                                                                                                                                                                                                                                                 Substance use (days of use, ASI, toxicology screens) structured interview and rating scales assessed by case manager; hospitalization rates; Quality of Life Interview; CM dosage: contacts per month with case manager   Every 6 months                                 Participants in both treatment conditions improved over time in multiple outcome domains, and few differences were found between the two models. Decreases in substance use were greater than would be expected given time alone. At the site that had higher rates of institutionalization, clients who received standard CM were more likely to be institutionalized. However, in the site that had lower rates of institutionalization, no differences in the rate of institutionalization were found between the two treatment conditions. At one site, the IG received a significantly higher dose (time and activities) of services than did the CG. At the other site, the difference was not significant. Integrated treatment can be successfully delivered either by assertive community treatment or by standard clinical CM
                                                                                                                                                                                                                                            IG: *n* = 99; CG: *n* = 99                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Huber et al. ([@B21]), USA                      Drug or alcohol users who were diagnosed with substance abuse disorder and enrolled at a substance abuse treatment facility                                                               *N* = 598\                                    Standard drug abuse treatment                                                                                                                 Community-based comprehensive CM intervention: 12 months of CM interventions consisted of four CM conditions with a case manager working as a member of drug-treatment staff (inside), a case manager from an outside social service agency (outside), or a case manager using computerized telecommunication (telecom). CG received standard drug abuse treatment. Five types of CM interventions were assessing, individual solution planning, referral, advocating, and conferencing                            CM dosage, ASI                                                                                                                                                                                                            3, 6, and 12 months                            Clients who engaged (actively participated) in CM were less likely to have legal and family issues, but more likely to have a chronic medical condition at baseline. Dosage factors differed significantly across treatment conditions. In general, dose was significantly related to outcomes in the legal and family domains
                                                                                                                                                                                                                                            IG: *n* = 437; CG: *n* = 149                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Lindahl et al. ([@B23]), Sweden (EU)            Court-ordered substance abuse patients                                                                                                                                                    *N* = 34\                                     TAU                                                                                                                                           Six months of CM intervention: case managers offered assessment, transitional care, support of referral services, and intervention to avoid crisis                                                                                                                                                                                                                                                                                                                                                                 Substance use (ASI, AUDIT, AUDRUG, SIP, days of alcohol used); psychological functioning; involuntary care (coercive measures); number of days in institutional or hospital care was measured                             6 and 12 months after discharge                More patients from the CM group were abstinent compared with those in the CG at the first follow-up at 6 months (46 vs. 14%, *p* \< 0.051).Patients in the CM group did not have more contact with health and social services (92%) compared with those in the CG (76%) (*p* = 0.23), nor did they have more medical-assisted treatment (*p* = 0.46) or institutional/inpatient care (*p* = 0.27) to a higher degree than patients in the CG.CM interventions were well received by the patients with no dropout during intervention. Patients with the support of a case manager seemed to sustain abstinence to a higher degree compared with TAU, but no differences were detected regarding use of care. A subgroup analysis showed that patients with continuous drug abuse had access to care from both social welfare and hospital care systems
                                                                                                                                                                                                                                            IG: *n* = 13; CG: *n* = 21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Morgenstern et al. ([@B22]), USA                Women with SUD receiving temporary assistance for needy families; not psychotic, under methadone treatment or seeking methadone treatment, or already in treatment program                *N* = 302\                                    TAU, which was standard substance abuse screening and referral system within welfare department                                               ICM intervention: CM services were provided throughout the 15-month follow-up period; assessment, planning, motivational enhancement, treatment coordination, peer support, and crisis management. If needed, case managers provided home visiting services. Contact was adapted to needs from daily to two visits per month                                                                                                                                                                                       Substance use (ASI, toxicology screen). Treatment attendance. Treatment engagement. Treatment retention rate                                                                                                              3, 9, and 15 months; 24 months (article 28)    ICM clients had significantly higher levels of substance abuse treatment initiation, engagement, and retention compared with CG clients. In some cases, ICM treatment attendance rates were double those of CG rates. Additionally, almost twice as many ICM clients were abstinent at the 15-month follow-up compared with CG clients (*p* \< 0.0025). After 24 months, abstinence rates were higher in the ICM group than they were for usual care. Additionally, there were greater odds of being employed full time
                                                                                                                                                                                                                                            IG: *n* = 161; CG: *n* = 141                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Morgenstern et al. ([@B31]): 24-month outcome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Morgenstern et al. ([@B29]), USA                SUD welfare applicants without acute psychotic symptoms and not more than one hospitalization for mental health problems in the last year                                                 *N* = 394 (66% men)\                          Usual care                                                                                                                                    CCM: continuity of care intervention focused on engaging clients in drug treatment, linking to needed ancillary services, and fostering transition to employment. Biweekly visit at treatment center and regular contact in office or by phone                                                                                                                                                                                                                                                                     Employment outcomes (days of employment and percentage of full-time employment), abstinence rates, treatment attendance                                                                                                   1-year follow-up                               Overall, men were more likely to work than women. There was no difference between groups. CCM increased women's employment over time. Among women only, greater SUD treatment attendance and abstinence in the first 6 months of CCM predicted higher rates of later employment
                                                                                                                                                                                                                                            IG: *n* = 221; CG: *n* = 173                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Plater-Zyberk et al. ([@B27]), ON, Canada       Patients enrolled in a methadone maintenance treatment program                                                                                                                            *N* = 1,704\                                  TAU: standard outpatient treatment                                                                                                            Clinical CM: duration and frequency varied according to clients' needs                                                                                                                                                                                                                                                                                                                                                                                                                                             Drug-positive urine samples, missed daily methadone doses, missed methadone physician appointments                                                                                                                        3 months                                       The IG demonstrated statistically significant improvement in all three measures of the methadone maintenance treatment program. Less drug-positive urine: 15.4% relative reduction. Fewer missed daily methadone doses: 2% relative reduction. Fewer missed appointments with the methadone physician: 40% relative reduction
                                                                                                                                                                                                                                            IG: *n* = 396; CG: *n* = 1,308                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Prendergast et al. ([@B28]), USA                Correction population who were enrolled in a drug-treatment program within a correctional institution (prison, work release, community correctional facility) in four states              *N* = 812 (men and women)\                    Standard referral/services (SR group)                                                                                                         TCM using the SBCM model: strengths assessment, conference call 1 month prior to release, community sessions. After release, weekly sessions for 3 months, followed by 3 monthly follow-up contacts for any client needing additional help                                                                                                                                                                                                                                                                         SUD treatment services, other social services, drug use, alcohol use, arrest, HIV risk behavior                                                                                                                           3 and 9 months following release from prison   There were no significant differences between parolees in the TCM group and the SR group on outcomes related to participation in drug abuse treatment, receipt of social services, or drug use, crime, and HIV risk behaviors. For specific services (e.g., residential treatment, mental health), although significant differences were found for length of participation or for number of visits, the number of participants in these services was small and the direction of effect was not consistent
                                                                                                                                                                                                                                            IG: *n* = 412; CG: *n* = 400                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Rapp et al. ([@B24]), USA                       Substance abusers seeking treatment; not psychotic and not only alcohol use disorder                                                                                                      *N* = 678. SBCM: *n* = 222\                   Standard care at a centralized intake unit                                                                                                    SBCM: assessing, individual solution planning, referral, advocating, and conferencing. Up to five sessions of SBCM. MI: clarify motivation, reinforce treatment-seeking behaviors. One 1-h interview                                                                                                                                                                                                                                                                                                               Linkage with SUD treatment within 90 days                                                                                                                                                                                 3 months                                       SBCM (*n* = 222) was more effective in improving linkage compared to CG (*n* = 230), 55.0 vs. 38.7%, respectively (*p* \< 0.01). SBCM improved linkage more than MI did (55.0 vs. 44.7%, *p* \< 0.05). MI (*n* = 226) was not significantly more effective in improving linkage than in CG (44.7 vs. 38.7%; *p* \> 0.05). The three trial groups differed only slightly on the client characteristics that predicted linkage with treatment
                                                                                                                                                                                                                                            One session of MI: *n* = 226; CG: *n* = 230                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Saleh et al. ([@B34]), USA                      Alcohol or drug abuse                                                                                                                                                                     *N* = 627                                     Usual care in treatment centers                                                                                                               12 months of CM services in community non-profit substance abuse treatment centers                                                                                                                                                                                                                                                                                                                                                                                                                                 Number of hospitalization days, number of ER visits, number of physician visits. Study 31: legal, employment, psychiatric improvements                                                                                    3, 6, and 12 months                            IGs showed decrease of the usage of mental health services. However, hospital usage, ER visits, and access to physicians were increased in IGs. The short duration of CM services was expected to increase the use of access outcomes. Study 32: legal, employment, and psychiatric improvements

  Saleh et al. ([@B35])                           IG: *n* = 437 (treatment agency: *n* = 167, social service agency: *n* = 160, telecom CM: *n* = 147);\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                  CG: *n* = 188                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Scott et al. ([@B33]), USA                      Substance abuse clients who used alcohol or other drugs in the past 6 months and who were enrolled in one of nine community substance abuse treatment facilities                          *N* = 692\                                    Usual care in community                                                                                                                       CM services over a 22-month period: assessment, referral services, client advocacy, counseling, and follow-up treatment                                                                                                                                                                                                                                                                                                                                                                                            Treatment retention, show rates to treatment                                                                                                                                                                                                                             IG was significantly more likely to show response to treatment than CG. No differences found in dose (amount or length of substance abuse treatment services) in both IG and CG
                                                                                                                                                                                                                                            IG: *n* = 344; CG: *n* = 348                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Siegal et al. ([@B25]), USA                     Veterans seeking treatment for substance abuse problems                                                                                                                                   *N* = 632\                                    CG: no CM group                                                                                                                               Veterans in the inpatient component participate in three phases lasting a total of 28 days. Outpatients attend 10 weeks of sessions involving education about substance abuse problems and group therapy sessions designed to assist in achieving abstinence. Both inpatient and outpatient clients are referred to an aftercare service upon completion of primary treatment. The clients in the IG received help for strengths assessment, identifying goals, and, if appropriate, accompaniment on job search   Substance use (ASI), psychosocial functioning, employment outcomes                                                                                                                                                        6 months                                       All clients showed significant improvement in employment outcomes, an increase of 6 days worked (*p* \< 0.01) in the last 30 days before the 3-month follow-up. SBCM reported 3.5 additional days worked compared to non-case-managed clients. There was a positive relationship between improved employment functioning and improvement in other life areas
                                                                                                                                                                                                                                            CM: *n* = 313; CG: *n* = 319                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Slesnick and Erdem ([@B32]), USA                Substance-abusing homeless mothers with a 2- to 6-year-old child                                                                                                                          *N* = 60\                                     Usual care in community                                                                                                                       Ecologically based treatment with CM services. The mothers were housed in apartments of their choosing and received 3 months of utility and rental assistance. CM services for 6 months, focusing on basic needs (i.e., referrals to food pantries); assisting, obtaining government entitlements; employment; connecting to social services; providing referrals and/or transportation to appointments. Average of 23.1 sessions in 6 months                                                                      Substance use, retention rate, independent living days                                                                                                                                                                    3, 6, and 9 months                             Mothers receiving ecologically based treatment showed a high retention rate on treatment, a faster decline in alcohol use (*p* \< 0.05), and a faster increase in their independent living days (*p* \< 0.001). Furthermore, with supportive services, two-thirds of women were successful in maintaining their apartments 6 months after rental assistance ended. However, no treatment effects were found in drug use (*p* \> 0.05)
                                                                                                                                                                                                                                            IG: *n* = 30; CG: *n* = 30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Strathdee et al. ([@B26]), USA                  Clients of the Baltimore Needle Exchange Program who sought drug abuse treatment                                                                                                          *N* = 245\                                    Passive referral \[voucher printed with date, time, and location for intake appointment (of opioid agonist) at the drug-treatment program\]   SBCM: engagement, strengths assessment, personal case planning, resource acquisition. The duration and frequency of CM contacts were client-driven, based on individual desires and needs                                                                                                                                                                                                                                                                                                                          Intake appointment for opioid agonist therapy within 7 days                                                                                                                                                               7 days                                         In a multivariate "intention-to-treat" model (i.e., ignoring the amount of CM actually received), those randomized to CM were more likely to enter treatment within 7 days (40 vs. control: 26%, *p* = 0.03). Additional "as-treated" analyses revealed that participants who received 30 min or more of CM within 7 days were 33% more likely to enter treatment. The active ingredient of CM activities was provision of transportation
                                                                                                                                                                                                                                            IG: *n* = 128; CG: *n* = 117                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*CM, case management; SUD, substance use disorder; IG, intervention group; CG, control group; PCM, probation case management; TAU, treatment as usual; ASI, Addiction Severity Index; BDI, Beck Depression Inventory; BSI, Brief Symptom Inventory; AUDIT, Alcohol Use Disorders Identification Test; AUDRUG, Drug Use Identification Test; SIP, Short Index of Problems; ICM, intensive case management; CCM, coordinated care management; SR, standard referral; TCM, transitional case management; SBCM, strengths-based case management; MI, motivational interviewing; ER, emergency room*.

The names of CM interventions varied in different studies. They were labeled "intensive," "community," or "assertive CM" ([@B20]--[@B22]); "strengths-based" ([@B23]--[@B26]), "clinical" ([@B27]), and "transitional CM" ([@B28]); or "coordinated care management" ([@B29]) and "probation CM" ([@B30]). Although the names and interventions varied, certain common characteristics could be found. CM services were conducted by case managers with a professional background in nursing, social work, or mental health care ([@B22]). CM services were delivered mainly in the patients' communities and not at the treatment center or hospital ([@B20]--[@B22]). The length of interventions varied from 1 month ([@B25]) to 3 years ([@B20]), although 6 months to 1 year was the most common. The intensity of the CM intervention was rarely noted.

Study Populations {#S3-1}
-----------------

In some studies, the population had SUD and no further differentiation was made, whereas other studies considered specific subgroups such as patients in methadone programs ([@B27]), women with SUD ([@B22], [@B31], [@B32]), and participants with court judgments who were either incarcerated or in court-ordered treatments ([@B23], [@B28], [@B30]). Most studies were done in the United States, except for the one by Prendergast et al. ([@B28]) in Canada and Lindhal et al. ([@B23]) in Sweden.

Outcome Measures {#S3-2}
----------------

The most frequently used outcome measures were change in drug or alcohol use, as well as adherence to SUD treatment (frequently measured in attendance rates) and linkage to other health-care providers. The other important outcome measures were health-care use in terms of days of hospitalization, emergency ward visits, or health costs. On a more general level, some studies measured global functioning; employment rates; reduction of social, legal, and family problems; and client satisfaction. Two studies concerning incarcerated or court-ordered individuals also used the number of post-enrollment arrests as an outcome measure ([@B28], [@B30]).

Most studies considered only SUD as an inclusion criterion. Surprisingly, the importance of comorbid mental health disorders or high service use was not defined as an inclusion criterion in most studies. Slesnick and Erdam's study ([@B32]) included only homeless mothers, and Morgenstern et al.'s studies ([@B22], [@B29], [@B31]) analyzed patients receiving welfare \[in one study ([@B22]), only women were included\]. Only Essock et al.'s study ([@B20]) used high service use, severe comorbid mental health disorder, unstable housing, and poor living skills as inclusion criteria. Some studies even excluded psychotic disorders ([@B22], [@B24]), and Morgenstern et al.'s study ([@B29]) excluded patients who had been hospitalized more than once for mental health reasons in the past year.

Effect of the Intervention {#S3-3}
--------------------------

Only two studies ([@B28], [@B30]) did not find any additional value in CM when treating addicted patients. The other 12 papers found significant improvement of some or all the outcome measures. These improvements were not the same for each survey.

Five studies showed that substance use decreased ([@B20], [@B22], [@B23], [@B27], [@B32]), two papers ([@B22], [@B26]) showed that the likelihood of initiating SUD treatment increased, and four publications ([@B22], [@B23], [@B27], [@B33]) showed greater treatment retention when a case manager was involved in treatment. Four studies ([@B23], [@B24], [@B33], [@B34]) showed improved access to health care and/or linkage between health-care providers. One research showed fewer days spent in hospital ([@B20]) but others reported an increased number of days in hospital, which is explained by the higher treatment retention ([@B34]). Seven publications showed better global functioning, which was described as more employment days ([@B25], [@B31], [@B35]). This was further differentiated in Morgenstern et al.'s study of 2008 ([@B29]), which showed that women were more likely than men to find employment when assisted by CM, to have fewer legal ([@B21], [@B35]) and family problems ([@B21]), and to have better housing stability ([@B32]). Lindahl et al. measured very high patient satisfaction with the treatment and 100% treatment retention compared to TAU ([@B23]).

Discussion {#S4}
==========

In most studies, significant improvements were reported in the outcome measures. Substance use decreased in only five papers ([@B20], [@B22], [@B23], [@B27], [@B32]), but treatment adherence and linkage between health-care providers seemed to improve in most surveys, which is an important issue for this population and one of the main aims of CM. Overall functioning improved in more than half of the studies, which is in general linked to higher life satisfaction.

The two publications ([@B28], [@B30]) that did not find significant improvements in one of the outcome measures were both performed with incarcerated or paroled patients. In Guydish et al.'s paper ([@B30]), the important factor was the limited face-to-face time. Only 53.6% of participants had seen their CM once or more during the first 6 months. For those participants who had seen their CM two or more times in the first 6 months, there was an improvement in substance use and social problems. This finding shows how important treatment intensity of CM is for the outcome. The other study with a negative outcome, by Prendergast et al. ([@B28]), showed no improvement in treatment participation for parolees with SUD who were receiving CM. However, this finding cannot be generalized, as the case manager's adherence to the protocol and the intervention was not standardized. Moreover, the case manager seemed to have limited contact with the parolee and the parolees did not enroll voluntarily in the project.

The studies are heterogeneous in their clinical approach, which limits our ability to generalize specific implications for practice. Different types of populations with different risk levels seem to account for the variation in readmission rates ([@B36]). For example, the study populations varied in illness severity (comorbidities and service use), which would most likely have an effect on the study outcome. Some comorbid populations were also excluded from surveys. The CM model is a specific intervention that seems more useful to specific subgroups who are unable to use existing health-care services. A large number of patients find adequate health care in the usual care programs, as shown in research on CM interventions that involve psychiatric patients with psychosis. Patients who benefit from CM have been shown to be those with greater social and psychosocial needs, more psychiatric symptoms, and higher service use ([@B37]), with others not needing this specific intensive care ([@B38]). If CM is applied to a large group, the effect on a smaller subgroup would likely be diluted and not as visible in the outcome measures. It will be important to further specify these subgroups in future in order to refer patients to the appropriate programs.

The intensity of application of CM differs in these studies, which also limits our ability to generalize the effects ([@B39]). These examples show the importance of face-to-face time with patients, which can be managed only with small caseloads. This seems to have been a limiting factor in the two studies ([@B28], [@B30]) mentioned above. In addition, the adherence to the model by the case manager and the voluntary participation of the patients seem to affect the outcome.

The majority of the studies were performed in the United States, which is a limiting factor in generalizing these findings to other countries such as those in Europe, where health systems differ in organization and funding. A further limitation of this research was that the data search was performed only on the PubMed database and possibly that unpublished negative studies were not taken into account. Furthermore, we did not differentiate between alcohol use disorder and other SUDs.

Conclusion {#S5}
==========

Most of the analyzed studies showed improvement in the chosen outcome measures, although these varied in different studies. Treatment adherence mostly improved, but substance use decreased in only a third of the studies. Overall functioning improved in about half of the studies. The differences in chosen outcome measures make it difficult to compare the results. The type of intervention and intensity of treatment also varied.

The heterogeneity of these results might be linked to the different types of populations studied. The specific CM intervention seems to be helpful only for specific subpopulations with SUDs. Further studies are necessary to determine inclusion criteria for CM treatment for patients with SUD in order to orientate those most likely to benefit from this approach to the specific CM programs.

Only a few studies on this intervention and SUD have been published. Further research is needed to examine the effect of treatment intensity of the CM intervention. Longitudinal studies are also needed in Europe to ensure the effectiveness of these treatments.
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